The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and ...
As we approach the first anniversary of omalizumab’s approval for food allergy, its use is “definitely going to grow,” Robert ...
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...
Dry Eye Syndrome Treatment Market Advancements in AI Diagnostics, Drug-Device Therapies, and Regenerative Medicine are Fueling Market Expan ...
A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis ...
The World EPA organisers have curated an exceptional programme featuring thought-provoking presentations and dynamic panel ...
Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...
Your local pharmacy might be the next front in Donald Trump’s trade war. The president has in recent weeks promised to impose tariffs on all foreign-made medications, a move intended to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results